CSC HOLDINGS - CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities:
Net income	$ 315,681	$ 479,473
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization (including impairments)	881,474	879,184
Loss (gain) on derivative contracts, net	(320,188)	152,405
Gain (Loss) on Extinguishment of Debt	0	51,712
Amortization of deferred financing costs and discounts (premiums) on indebtedness	41,150	45,917
Share-based compensation expense	77,061	55,927
Deferred income taxes	(57,720)	98,769
Operating Lease, Right-of-Use Asset, Amortization Expense	22,139	21,691
Provision for doubtful accounts	36,839	28,154
Other	(321)	4,344
Change in assets and liabilities, net of effects of acquisitions and dispositions:
Accounts receivable, trade	(790)	13,078
Prepaid expenses and other assets	6,689	31,631
Amounts due from and due to affiliates	(6,057)	6,505
Accounts payable and accrued liabilities	(1,527)	(117,467)
Deferred revenue	(1,906)	5,782
Liabilities related to interest rate swap contracts	(192,344)	(79,468)
Net cash provided by operating activities	1,276,554	1,479,165
Cash flows from investing activities:
Capital expenditures	(877,497)	(535,895)
Payments for acquisitions, net of cash acquired	0	(340,570)
Other, net	(610)	(1,074)
Net cash used in investing activities	(878,107)	(877,539)
Cash flows from financing activities:
Proceeds from long-term debt	460,000	3,160,000
Repayment of long-term debt	(758,861)	(3,057,469)
Proceeds from collateralized indebtedness and related derivative contracts, net	0	185,105
Repayment of collateralized indebtedness and related derivative contracts, net	0	(185,105)
Principal payments on finance lease obligations	(62,221)	(37,560)
Other	0	1,339
Net cash used in financing activities	(361,082)	(659,208)
Net increase (decrease) in cash and cash equivalents	37,365	(57,582)
Net increase (decrease) in cash and cash equivalents	37,255	(57,103)
Cash, cash equivalents and restricted cash at beginning of year	195,975	278,686
Cash, cash equivalents and restricted cash at end of period	233,230	221,583
Gain (loss) on investments	(476,374)	198,472
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(110)	479
CSC Holdings
Cash flows from operating activities:
Net income	315,681	481,770
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization (including impairments)	881,474	879,184
Loss (gain) on derivative contracts, net	(320,188)	152,405
Gain (Loss) on Extinguishment of Debt	0	51,712
Amortization of deferred financing costs and discounts (premiums) on indebtedness	41,150	45,917
Share-based compensation expense	77,061	55,927
Deferred income taxes	(57,720)	87,021
Operating Lease, Right-of-Use Asset, Amortization Expense	22,139	21,691
Provision for doubtful accounts	36,839	28,154
Other	(321)	4,344
Change in assets and liabilities, net of effects of acquisitions and dispositions:
Accounts receivable, trade	(790)	13,078
Prepaid expenses and other assets	6,689	31,844
Amounts due from and due to affiliates	(6,057)	(13,903)
Accounts payable and accrued liabilities	(1,527)	(117,226)
Deferred revenue	(1,906)	5,782
Liabilities related to interest rate swap contracts	(192,344)	(79,468)
Net cash provided by operating activities	1,276,554	1,449,760
Cash flows from investing activities:
Capital expenditures	(877,497)	(535,895)
Payments for acquisitions, net of cash acquired	0	(340,570)
Other, net	(610)	(1,074)
Net cash used in investing activities	(878,107)	(877,539)
Cash flows from financing activities:
Proceeds from long-term debt	460,000	3,160,000
Repayment of long-term debt	(758,861)	(3,057,469)
Proceeds from collateralized indebtedness and related derivative contracts, net	0	185,105
Repayment of collateralized indebtedness and related derivative contracts, net	0	(185,105)
Distributions to parent	0	685,478
Principal payments on finance lease obligations	(62,221)	(37,560)
Other	0	(9,024)
Net cash used in financing activities	(361,082)	(629,531)
Net increase (decrease) in cash and cash equivalents	37,365	(57,310)
Net increase (decrease) in cash and cash equivalents	37,255	(56,831)
Cash, cash equivalents and restricted cash at beginning of year	193,418	278,202
Cash, cash equivalents and restricted cash at end of period	230,673	221,371
Gain (loss) on investments	(476,374)	198,472
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ (110)	$ 479